1. Home
  2. ACGL vs ONC Comparison

ACGL vs ONC Comparison

Compare ACGL & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arch Capital Group Ltd.

ACGL

Arch Capital Group Ltd.

HOLD

Current Price

$100.30

Market Cap

34.0B

Sector

Finance

ML Signal

HOLD

ONC

BeiGene Ltd. American Depositary Shares

HOLD

Current Price

$347.16

Market Cap

34.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACGL
ONC
Founded
2001
2010
Country
Bermuda
Switzerland
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.0B
34.8B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
ACGL
ONC
Price
$100.30
$347.16
Analyst Decision
Buy
Strong Buy
Analyst Count
16
12
Target Price
$107.87
$370.25
AVG Volume (30 Days)
2.4M
241.8K
Earning Date
02-09-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
3.66
N/A
EPS
11.60
0.58
Revenue
$19,929,000,000.00
$4,972,687,000.00
Revenue This Year
N/A
$895.40
Revenue Next Year
$4.56
$22.04
P/E Ratio
$8.50
$600.76
Revenue Growth
14.27
50.43
52 Week Low
$82.45
$196.45
52 Week High
$103.39
$385.22

Technical Indicators

Market Signals
Indicator
ACGL
ONC
Relative Strength Index (RSI) 63.17 53.80
Support Level $94.84 $340.00
Resistance Level $102.90 $358.38
Average True Range (ATR) 2.40 9.75
MACD 0.39 -0.25
Stochastic Oscillator 73.83 60.47

Price Performance

Historical Comparison
ACGL
ONC

About ACGL Arch Capital Group Ltd.

Arch Capital Group Ltd is a Bermuda company that writes insurance and reinsurance with operations in the United States, Canada, Europe, Australia, and the United Kingdom. The business operates through three underwriting segments: insurance, reinsurance, and mortgage. The insurance segment provides specialty risk solutions to clients across various industries. The reinsurance segment provides reinsurance services which cover property catastrophe, property, liability, marine, aviation and space, trade credit and surety, agriculture, accident, life and health, and political risk. The mortgage business provides risk management and risk financing products to the mortgage insurance sectors through platforms in the U.S., Europe and Bermuda.

About ONC BeiGene Ltd. American Depositary Shares

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.

Share on Social Networks: